Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 14, 2025 • 7:01 PM ET

Date/Time Source News Release
07/09/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026
06/18/2025 11:19 AM EDT Canada Newswire Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going
06/10/2025 08:56 AM EDT GlobeNewswire Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension
05/15/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
05/12/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
04/15/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress
03/31/2025 08:00 AM EDT GlobeNewswire Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
02/18/2025 08:00 AM EST GlobeNewswire Galectin Therapeutics Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial
01/10/2025 08:00 AM EST GlobeNewswire Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
12/20/2024 08:00 AM EST GlobeNewswire Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH
Page

Additional News

As of July 14, 2025 • 7:01 PM ET

Date/Time Source News Release
07/09/2025 08:13 AM EDT SeekingAlpha Galectin Therapeutics announces new $10 million credit line from Richard Uihlein,
06/18/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Stock Dilution and Cannabis Earnings Drive Indices Lower
06/18/2025 10:22 AM EDT USA News Group Cancer Rates Are Surging in Young Adults - Here's Where the Smart Money Is Going
06/17/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Oil Rises on Geopolitical Risk and Strong Ad Tech Earnings
06/16/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Geopolitical Risk and Aquisition Activity Drive Index Action
05/16/2025 05:30 AM EDT US Earnings Reports Expected earnings - Galectin Therapeutics Inc.
05/15/2025 08:20 AM EDT SeekingAlpha Galectin Therapeutics GAAP EPS of -$0.15
04/07/2025 09:40 AM EDT Zacks Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
04/01/2025 05:30 AM EDT US Earnings Reports Expected earnings - Galectin Therapeutics Inc.
03/31/2025 08:10 AM EDT SeekingAlpha Galectin Therapeutics GAAP EPS of -$0.76
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.